Medpace Holdings, Inc.

Medpace Holdings provides clinical research services supporting drug and medical device development across the full spectrum of clinical trials, from Phase I through Phase IV. The company serves pharmaceutical, biotechnology, and medical device manufacturers with a comprehensive range of development services including clinical monitoring, data management and analysis, regulatory affairs support, and pharmacovigilance services. Additionally, Medpace operates specialized functions such as bio-analytical laboratory testing, clinical human pharmacology studies, imaging services, and electrocardiography reading support for trials across multiple therapeutic areas.

The company maintains a global footprint with operations spanning North America, Europe, Asia, South America, Africa, and Australia, enabling it to support multinational clinical development programs. Medpace employs approximately 6,200 full-time staff and operates from its headquarters in Cincinnati, Ohio, where it was established in 1992. The organization's service portfolio positions it within the contract research organization market, which supports the outsourced development activities of its pharmaceutical and medical device clients.